Here is a EVMS protocol being suggested and used by hospitals to address three of the big life-threatening problems created by SARS-COV2. That is the immune dysregulation and hyper-inflammation (cytokine storm), the hyper-coagulability (increased clotting) and the severe hypoxemia (low oxygen levels). Reports show that patients can benefit by being prone with oxygen but avoiding the ventilator. Several video links are listed below to help explain this protocol and ventilator complications.
Medications (HCG, remdesivir, many more) and nutritionals (including vitamin C & D, zinc, quercetin, melatonin, thiamine B1 and magnesium) are detailed. NAC & Glutathione,vitamin K, calcium and CoQ10 or Ubiquinol are added for additional discussed benefits. See more explanations for each of these supplements and how they work under our Key Supplement Reviews tab: Essential Minerals (Ca Mg, Zn), Essential Vitamins (B, C), Essential Vitamins (A, D, E, K), Super Cell Protectors (NAC, quercetin, CoQ10), and Unique Immune Support (melatonin) .
**IF YOU CARE FOR COVID PATIENTS AT ANY LEVEL, OR ARE HIGH RISK YOURSELF, YOU WILL FIND THESE VIDEOS HELPFUL.
>>At Home Patient Management MATH+ Protocol Part 1 by DrBeen Medical Lectures - June 2020 for COVID-19
>>Basic Hospital Care MATH+ Protocol Part 2 by DrBeen Medical Lectures - June 2020 for COVID-19
>>Advanced Hospital ICU MATH+ Protocol Part 3 by DrBeen Medical Lectures - June 2020 for COVID-19
>>Small Update for MATH+ Protocol by DrBeen Medical Lectures - June 18, 2020 hydroxychloroquine discussion
>>Link to the actual MATH protocol from Eastern Virginia Medical School - Medical success with COVID-19 treatment
See also our pages on Inflammation and Cytokine Storms. If you watch our other videos, you will see find information regarding the use of various herbs and nutrition therapy and how they can support the body during problems like these and help reduce long term complications.
Also, an interesting June 6, report from The Canadian Press: "The Journal of the American Geriatrics Society has calculated the percentage of COVID-19 deaths in long-term care facilities for several countries and U.S. states. The numbers run from 63 percent in Massachusetts to 71 per cent in Connecticut — although the journal warns 11 states don't report COVID-19 deaths in such facilities. In Canada, the figure for early May was 82 per cent. About half of European COVID-19 deaths were in long-term care. Hong Kong reported no such deaths. South Korea, Singapore and New Zealand each had fewer than 20."
>>UK News Interview: Why We Might Not Need a Vaccine for COVID-19 - June 2020 opinion
>>Discussion about SARS-COV2 Antibodies and long-term Immunity by Dr. Rhonda Patrick - June 2020 research reviews
Is SARS-COV2 getting weaker? Here is an interesting review of viral replication and mutation. When a virus hijacks a cell and uses it to reproduce, it can mutate (genetically change) from environmental or chemical (medications) pressure. If the pathogen is very strong (virile) it will create rapid, severe symptoms in the patient (likely causing them to stay in bed) and limiting exposure to those who come to the patient. If the patient dies, the pathogen will die and terminate, provided that the host is buried in a sanitary manor. The more severe and rapid the symptoms, the less the virus is able to freely spread without warning. This mutation path is somewhat self-limiting as described and not favorable to spread of this severe strain. (Of course depending on the method of transmission, incubation and infectious periods, local hygiene and immune response.) On the other hand, if the viral modification is mild and generally creates minimal symptoms, the patient will likely remain mobile and come into contact with and possibly infect many more people during the infectious period. This path favors the spread of the more mild strain. Further, if the mild version of the virus allows protective antibodies to be created against the more virile strain, then the mild mutation is likely to be the dominant strain. Most viruses do not fully go away, rather they "burn" out once the population infection rate approaches herd immunity e.g. 70-80% and there are fewer new hosts. The various strains may continue to circulate through the population from time to time. There is a similar story with bacteria- and sometimes the virulent drug resistant strains do develop. (See June 2020, DrBeen Youtube "Is SARS-COV2 getting weaker?" if you want the 45 minute version.)